The company, part of Malaysia’s Genting Group, wants the state to lower its proposed tax rate or raise the levy that may be imposed on the other bidders.
Clients increasingly view their accountants not just as compliance partners, but as essential growth engines. They don’t just need a tax return and help with compliance, they need a strategic partner.
Halda Therapeutics is developing oral assets for prostate and lung cancer. The deal comes after Johnson & Johnson set an ambitious goal for its oncology sales by 2030.
Artios Pharma is working on a pipeline of oncology assets, led by alnodesertib, currently being tested for second-line pancreatic cancer and third-line colorectal cancer.
Aside from announcing layoffs, Sensei has decided to terminate its R&D work. The biotech has $25 million on hand, and continues to evaluate its strategic alternatives.
Pressure from political activist Laura Loomer apparently torpedoed the nomination of Donald Korb, who had previously served as chief counsel under President George W. Bush.